1. Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical Care Costs Associated with Cancer Survivorship in the United States. Cancer Epidemiology and Prevention Biomarkers. AACR; 2020;
2. Grimshaw JM, Patey AM, Kirkham KR, Hall A, Dowling SK, Rodondi N, et al. De-implementing wisely: developing the evidence base to reduce low-value care. BMJ Quality & Safety. BMJ Publishing Group Ltd; 2020;29:409–17.
3. Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implementation Science. 2014;9:1.
4. Maratt JK, Kerr EA, Klamerus ML, Lohman SE, Froehlich W, Bhatia RS, et al. Measures used to assess the impact of interventions to reduce low-value care: A systematic review. Journal of general internal medicine. Springer; 2019;1–8.
5. Baker A. Crossing the quality chasm: a new health system for the 21st century. British Medical Journal Publishing Group; 2001.
6. Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. New England Journal of Medicine. Mass Medical Soc; 2009;360:1310–9.
7. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine. Mass Medical Soc; 2009;360:1320–8.
8. Saini V, Lin KW. Introducing Lown Right Care: reducing overuse and underuse. American family physician. 2018;98:560–560.
9. Boughey JC, Haffty BG, Habermann EB, Hoskin TL, Goetz MP. Has the time come to stop surgical staging of the axilla for all women age 70 years or older with hormone receptor-positive breast cancer? Annals of surgical oncology. Springer; 2017;24:614–7.
10. Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA. ‘Choosing Wisely’: a growing international campaign. BMJ quality & safety. BMJ Publishing Group Ltd; 2015;24:167–74.
11. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. Jama. American Medical Association; 2012;307:1801–2.
12. Baskin AS, Wang T, Berlin NL, Skolarus TA, Dossett LA. Scope and Characteristics of Choosing Wisely in Cancer Care Recommendations by Professional Societies. JAMA oncology. American Medical Association; 2020;6:1463–5.
13. Schleicher SM, Bach PB, Matsoukas K, Korenstein D. Medication overuse in oncology: current trends and future implications for patients and society. The Lancet Oncology. Elsevier; 2018;19:e200–8.
14. Baxi SS, Kale M, Keyhani S, Roman BR, Yang A, Derosa A, et al. Overuse of health care services in the management of cancer: a systematic review. Medical care. NIH Public Access; 2017;55:723.
15. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. American Society of Clinical Oncology Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.
16. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, Group EGW. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. Oxford University Press; 2012;23:vii11–9.
17. Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N, et al. Factors associated with imaging in patients with early breast cancer after initial treatment. Current Oncology. Multimed Inc.; 2018;25:126.
18. Simos D, Catley C, van Walraven C, Arnaout A, Booth CM, McInnes M, et al. Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study. CMAJ. Can Med Assoc; 2015;187:E387–97.
19. Colla CH, Mainor AJ, Hargreaves C, Sequist T, Morden N. Interventions aimed at reducing use of low-value health services: a systematic review. Medical Care Research and Review. SAGE Publications Sage CA: Los Angeles, CA; 2017;74:507–50.
20. Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, et al. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC medicine. BioMed Central; 2015;13:1–21.
21. Norton WE, Chambers DA. Unpacking the complexities of de-implementing inappropriate health interventions. Implementation Science. Springer; 2020;15:1–7.
22. Ritchie J, Lewis J, Nicholls CM, Ormston R. Qualitative research practice: A guide for social science students and researchers. sage; 2013.
23. McKay VR, Morshed AB, Brownson RC, Proctor EK, Prusaczyk B. Letting go: Conceptualizing intervention de‐implementation in public health and social service settings. American journal of community psychology. Wiley Online Library; 2018;62:189–202.
24. Morgan DJ, Leppin A, Smith CD, Korenstein D. A practical framework for understanding and reducing medical overuse: conceptualizing overuse through the patient-clinician interaction. Journal of hospital medicine. NIH Public Access; 2017;12:346.
25. Study Quality Assessment Tools | NHLBI, NIH [Internet]. [cited 2021 Apr 12]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
26. Howard DH, Tangka FK, Guy GP, Ekwueme DU, Lipscomb J. Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Affairs. 2013;32:596–602.
27. Saletti P, Sanna P, Gabutti L, Ghielmini M. Choosing wisely in oncology: necessity and obstacles. Esmo Open. BMJ Publishing Group Limited; 2018;3:e000382.
28. Encinosa W, Davidoff AJ. Changes in antiemetic overuse in response to choosing wisely recommendations. JAMA oncology. American Medical Association; 2017;3:320–6.
29. Norton WE, Chambers DA, Kramer BS. Conceptualizing de-implementation in cancer care delivery. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018;37:93–6.
30. Tabriz AA, Neslund-Dudas C, Turner K, Rivera MP, Reuland DS, Lafata JE. How Health-Care Organizations Implement Shared Decision-making When It Is Required for Reimbursement: The Case of Lung Cancer Screening. Chest. Elsevier; 2021;159:413–25.
31. Schleifer D, Rothman DJ. “The ultimate decision is yours”: exploring patients’ attitudes about the overuse of medical interventions. PloS one. Public Library of Science; 2012;7:e52552.
32. Gogineni K, Shuman KL, Chinn D, Gabler NB, Emanuel EJ. Patient demands and requests for cancer tests and treatments. JAMA oncology. American Medical Association; 2015;1:33–9.
33. Carman KL, Maurer M, Yegian JM, Dardess P, McGee J, Evers M, et al. Evidence that consumers are skeptical about evidence-based health care. Health Affairs. 2010;29:1400–6.
34. Augustsson H, Ingvarsson S, Nilsen P, von Thiele Schwarz U, Muli I, Dervish J, et al. Determinants for the use and de-implementation of low-value care in health care: a scoping review. Implementation science communications. Springer; 2021;2:1–17.
35. Helfrich CD, Hartmann CW, Parikh TJ, Au DH. Promoting health equity through de-implementation research. Ethnicity & disease. Ethnicity & Disease Inc.; 2019;29:93.
36. Schpero WL, Morden NE, Sequist TD, Rosenthal MB, Gottlieb DJ, Colla CH. For selected services, blacks and Hispanics more likely to receive low-value care than whites. Health Affairs. 2017;36:1065–9.
37. Webb Hooper M, Mitchell C, Marshall VJ, Cheatham C, Austin K, Sanders K, et al. Understanding multilevel factors related to urban community trust in healthcare and research. International journal of environmental research and public health. Multidisciplinary Digital Publishing Institute; 2019;16:3280.
38. Helfrich CD, Rose AJ, Hartmann CW, van Bodegom‐Vos L, Graham ID, Wood SJ, et al. How the dual process model of human cognition can inform efforts to de‐implement ineffective and harmful clinical practices: A preliminary model of unlearning and substitution. Journal of evaluation in clinical practice. Wiley Online Library; 2018;24:198–205.
39. Bierbaum M, Rapport F, Arnolda G, Nic Giolla Easpaig B, Lamprell K, Hutchinson K, et al. Clinicians’ attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature. Implementation Science. Springer; 2020;15:1–24.
40. Chambers DA, Vinson CA, Norton WE. Advancing the science of implementation across the cancer continuum. Oxford University Press; 2018.
41. Wang T, Bredbeck BC, Sinco B, Shubeck S, Baskin AS, Skolarus T, et al. Variations in Persistent Use of Low-Value Breast Cancer Surgery. JAMA surgery. 2021;
42. Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA internal medicine. 2015;175:274–86.
43. Garner S, Docherty M, Somner J, Sharma T, Choudhury M, Clarke M, et al. Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviews. Journal of health services research & policy. SAGE Publications Sage UK: London, England; 2013;18:6–12.